{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:22:26Z","timestamp":1788801746424,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National research foundation of Korea","doi-asserted-by":"crossref","award":["2020R1C1C1015104"],"award-info":[{"award-number":["2020R1C1C1015104"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s40256-024-00717-6","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T10:31:06Z","timestamp":1736591466000},"page":"419-425","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Incidence and Risk Factors for Amiodarone-Induced Thyroid Dysfunction: A Nationwide Retrospective Cohort Study"],"prefix":"10.1007","volume":"25","author":[{"given":"Seo Young","family":"Sohn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungsoo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Woo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,11]]},"reference":[{"issue":"9","key":"717_CR1","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1056\/NEJMct065916","volume":"356","author":"P Zimetbaum","year":"2007","unstructured":"Zimetbaum P. Amiodarone for atrial fibrillation. N Engl J Med. 2007;356(9):935\u201341.","journal-title":"N Engl J Med"},{"issue":"7","key":"717_CR2","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1001\/archinte.166.7.719","volume":"166","author":"C Lafuente-Lafuente","year":"2006","unstructured":"Lafuente-Lafuente C, Mouly S, Long\u00e1s-Tejero MA, Mah\u00e9 I, Bergmann JF. Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials. Arch Intern Med. 2006;166(7):719\u201328.","journal-title":"Arch Intern Med"},{"issue":"9","key":"717_CR3","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.hrthm.2007.07.020","volume":"4","author":"N Goldschlager","year":"2007","unstructured":"Goldschlager N, Epstein AE, Naccarelli GV, Olshansky B, Singh B, Collard HR, et al. A practical guide for clinicians who treat patients with amiodarone: 2007. Heart Rhythm. 2007;4(9):1250\u20139.","journal-title":"Heart Rhythm"},{"issue":"3","key":"717_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/1715163516641136","volume":"149","author":"JE Tisdale","year":"2016","unstructured":"Tisdale JE. Drug-induced QT interval prolongation and torsades de pointes: role of the pharmacist in risk assessment, prevention and management. Can Pharm J (Ott). 2016;149(3):139\u201352.","journal-title":"Can Pharm J (Ott)."},{"issue":"7","key":"717_CR5","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.amjmed.2004.11.028","volume":"118","author":"S Basaria","year":"2005","unstructured":"Basaria S, Cooper DS. Amiodarone and the thyroid. Am J Med. 2005;118(7):706\u201314.","journal-title":"Am J Med"},{"issue":"1\u20134","key":"717_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000180696","volume":"26","author":"E Martino","year":"1987","unstructured":"Martino E, Aghini-Lombardi F, Mariotti S, Bartalena L, Braverman L, Pinchera A. Amiodarone: a common source of iodine-induced thyrotoxicosis. Horm Res. 1987;26(1\u20134):158\u201371.","journal-title":"Horm Res"},{"issue":"1","key":"717_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nrendo.2009.225","volume":"6","author":"J Cohen-Lehman","year":"2010","unstructured":"Cohen-Lehman J, Dahl P, Danzi S, Klein I. Effects of amiodarone therapy on thyroid function. Nat Rev Endocrinol. 2010;6(1):34\u201341.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"717_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1530\/EJE-14-0267","volume":"171","author":"L Tomisti","year":"2014","unstructured":"Tomisti L, Rossi G, Bartalena L, Martino E, Bogazzi F. The onset time of amiodarone-induced thyrotoxicosis (AIT) depends on AIT type. Eur J Endocrinol. 2014;171(3):363\u20138.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"717_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1210\/clinem\/dgaa686","volume":"106","author":"D Ylli","year":"2021","unstructured":"Ylli D, Wartofsky L, Burman KD. Evaluation and treatment of amiodarone-induced thyroid disorders. J Clin Endocrinol Metab. 2021;106(1):226\u201336.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"717_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.7326\/0003-4819-101-1-28","volume":"101","author":"E Martino","year":"1984","unstructured":"Martino E, Safran M, Aghini-Lombardi F, Rajatanavin R, Lenziardi M, Fay M, et al. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med. 1984;101(1):28\u201334.","journal-title":"Ann Intern Med"},{"issue":"3","key":"717_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1365-2265.2011.04087.x","volume":"75","author":"S Ahmed","year":"2011","unstructured":"Ahmed S, Van Gelder IC, Wiesfeld AC, Van Veldhuisen DJ, Links TP. Determinants and outcome of amiodarone-associated thyroid dysfunction. Clin Endocrinol (Oxf). 2011;75(3):388\u201394.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"717_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/534904","volume":"2014","author":"T Uchida","year":"2014","unstructured":"Uchida T, Kasai T, Takagi A, Sekita G, Komiya K, Takeno K, et al. Prevalence of amiodarone-induced thyrotoxicosis and associated risk factors in Japanese patients. Int J Endocrinol. 2014;2014: 534904.","journal-title":"Int J Endocrinol."},{"issue":"3","key":"717_CR13","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.ijcard.2012.02.015","volume":"167","author":"MN Stan","year":"2013","unstructured":"Stan MN, Ammash NM, Warnes CA, Brennan MD, Thapa P, Nannenga MR, et al. Body mass index and the development of amiodarone-induced thyrotoxicosis in adults with congenital heart disease\u2014a cohort study. Int J Cardiol. 2013;167(3):821\u20136.","journal-title":"Int J Cardiol"},{"issue":"12","key":"717_CR14","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/qjmed\/hcg158","volume":"96","author":"J Sidhu","year":"2003","unstructured":"Sidhu J, Jenkins D. Men are at increased risk of amiodarone-associated thyrotoxicosis in the UK. QJM. 2003;96(12):949\u201350.","journal-title":"QJM"},{"issue":"1","key":"717_CR15","first-page":"2","volume":"63","author":"I Zosin","year":"2012","unstructured":"Zosin I, Bala\u015f M. Amiodarone-induced thyroid dysfunction in an iodine-replete area: epidemiological and clinical data. Endokrynol Pol. 2012;63(1):2\u20139.","journal-title":"Endokrynol Pol"},{"issue":"6","key":"717_CR16","first-page":"434","volume":"16","author":"KF Lee","year":"2010","unstructured":"Lee KF, Lee KM, Fung TT. Amiodarone-induced thyroid dysfunction in the Hong Kong Chinese population. Hong Kong Med J. 2010;16(6):434\u20139.","journal-title":"Hong Kong Med J"},{"issue":"2","key":"717_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s11096-013-9910-9","volume":"36","author":"CJ Huang","year":"2014","unstructured":"Huang CJ, Chen PJ, Chang JW, Huang DF, Chang SL, Chen SA, et al. Amiodarone-induced thyroid dysfunction in Taiwan: a retrospective cohort study. Int J Clin Pharm. 2014;36(2):405\u201311.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"717_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1210\/jc.2008-1907","volume":"94","author":"KH Yiu","year":"2009","unstructured":"Yiu KH, Jim MH, Siu CW, Lee CH, Yuen M, Mok M, et al. Amiodarone-induced thyrotoxicosis is a predictor of adverse cardiovascular outcome. J Clin Endocrinol Metab. 2009;94(1):109\u201314.","journal-title":"J Clin Endocrinol Metab"},{"issue":"24","key":"717_CR19","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.jacc.2007.02.054","volume":"49","author":"D Conen","year":"2007","unstructured":"Conen D, Melly L, Kaufmann C, Bilz S, Ammann P, Schaer B, et al. Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcome. J Am Coll Cardiol. 2007;49(24):2350\u20135.","journal-title":"J Am Coll Cardiol"},{"key":"717_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.680647","volume":"12","author":"SY Sohn","year":"2021","unstructured":"Sohn SY, Seo GH, Chung JH. Risk of all-cause mortality in levothyroxine-treated hypothyroid patients: a nationwide Korean cohort study. Front Endocrinol (Lausanne). 2021;12: 680647.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"9","key":"717_CR21","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1210\/JC.2015-2329","volume":"100","author":"E Kornelius","year":"2015","unstructured":"Kornelius E, Chiou JY, Yang YS, Peng CH, Lai YR, Huang CN. Iodinated contrast media increased the risk of thyroid dysfunction: a 6-year retrospective cohort study. J Clin Endocrinol Metab. 2015;100(9):3372\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"717_CR22","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/cen.14424","volume":"94","author":"M Thvilum","year":"2021","unstructured":"Thvilum M, Brandt F, Lillevang-Johansen M, Folkestad L, Brix TH, Hegedus L. Increased risk of dementia in hypothyroidism: a Danish nationwide register-based study. Clin Endocrinol (Oxf). 2021;94(6):1017\u201324.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"717_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1161\/01.CIR.100.2.149","volume":"100","author":"SA Thorne","year":"1999","unstructured":"Thorne SA, Barnes I, Cullinan P, Somerville J. Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease. Circulation. 1999;100(2):149\u201354.","journal-title":"Circulation"},{"issue":"2","key":"717_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190738","volume":"13","author":"SY Park","year":"2018","unstructured":"Park SY, Kim HI, Oh HK, Kim TH, Jang HW, Chung JH, et al. Age- and gender-specific reference intervals of TSH and free T4 in an iodine-replete area: data from Korean National Health and Nutrition Examination Survey IV (2013\u20132015). PLoS\u00a0One. 2018;13(2): e0190738.","journal-title":"PLoS\u00a0One"},{"issue":"5","key":"717_CR25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/0002-9343(91)90187-3","volume":"91","author":"MD Trip","year":"1991","unstructured":"Trip MD, Wiersinga W, Plomp TA. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med. 1991;91(5):507\u201311.","journal-title":"Am J Med"},{"issue":"5","key":"717_CR26","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/ndt\/gfh096","volume":"19","author":"MR Wiederkehr","year":"2004","unstructured":"Wiederkehr MR, Kalogiros J, Krapf R. Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients. Nephrol Dial Transplant. 2004;19(5):1190\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"717_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.semnephrol.2021.03.008","volume":"41","author":"Y Narasaki","year":"2021","unstructured":"Narasaki Y, Sohn P, Rhee CM. The interplay between thyroid dysfunction and kidney disease. Semin Nephrol. 2021;41(2):133\u201343.","journal-title":"Semin Nephrol"},{"issue":"2","key":"717_CR28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/europace\/euac217","volume":"25","author":"SA Ali","year":"2023","unstructured":"Ali SA, Ersboll M, Vinding NE, Butt JH, Rorth R, Selmer C, et al. Incidence of thyroid dysfunction following initiation of amiodarone treatment in patients with and without heart failure: a nationwide cohort study. Europace. 2023;25(2):291\u20139.","journal-title":"Europace"},{"issue":"12","key":"717_CR29","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1111\/j.1464-5491.2012.03687.x","volume":"29","author":"JJ D\u00edez","year":"2012","unstructured":"D\u00edez JJ, Iglesias P. An analysis of the relative risk for hypothyroidism in patients with type 2 diabetes. Diabet Med. 2012;29(12):1510\u20134.","journal-title":"Diabet Med"},{"issue":"2","key":"717_CR30","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3803\/EnM.2018.33.2.260","volume":"33","author":"H Kwon","year":"2018","unstructured":"Kwon H, Jung JH, Han KD, Park YG, Cho JH, Lee DY, et al. Prevalence and annual incidence of thyroid disease in Korea from 2006 to 2015: A Nationwide Population-Based Cohort Study. Endocrinol Metab (Seoul). 2018;33(2):260\u20137.","journal-title":"Endocrinol Metab (Seoul)."},{"issue":"10","key":"717_CR31","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343\u2013421.","journal-title":"Thyroid"},{"issue":"1","key":"717_CR32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/jep.12619","volume":"23","author":"CJ Huang","year":"2017","unstructured":"Huang CJ, Tseng CL, Chu CH, Huang DF, Huang CC, Lin LY. Adherence to guidelines in monitoring amiodarone-induced thyroid dysfunction. J Eval Clin Pract. 2017;23(1):108\u201313.","journal-title":"J Eval Clin Pract"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-024-00717-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-024-00717-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-024-00717-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T12:14:41Z","timestamp":1745324081000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-024-00717-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,11]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["717"],"URL":"https:\/\/doi.org\/10.1007\/s40256-024-00717-6","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,11]]},"assertion":[{"value":"15 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Conceptualization: S.Y.S. and S.W.C. Data curation: S.Y.S., Y.J.K., and S.W.C. Formal analysis: Y.J.K. Investigation: S.Y.S., S.C., and S.W.C. Methodology: S.Y.S. and Y.J.K. Project administration: S.W.C. and S.C. Supervision: S.C. and S.W.C. Writing-original draft: S.Y.S. Writing-review and editing: S.Y.S., S.C., and S.W.C. All authors contributed to the article and approved the submitted version.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contribution"}},{"value":"S.W.C. was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea as funded by the Ministry of Science and ICT (MSIT) (2020R1C1C1015104).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors are restricted from sharing the data underlying this study because the Korean National Health Insurance Service (NHIS) owns the data. Researchers can request access on the NHIS website (). Details of this process and a provision guide are available at ().","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"This study was performed in accordance with the Helsinki Declaration and was approved by the institutional review board of Myongji Hospital (no. 2020-03-016).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The institutional review board of Myongji Hospital confirmed that the requirement for obtaining informed consent was not applicable because this study used anonymous administrative claim data.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"No data belonging to individuals are included in this manuscript.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no conflicts of interest to declare.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}